New York v. Feldman, 2003 U.S. Dist. LEXIS 11759, 01-Civ. 6691 (SAS) (S.D.N.Y.), 210 F. Supp. 2d 294 (S.D.N.Y 2002)
Plaintiff States sought restitution on behalf of all persons injured as a result of Defendants alleged bid-rigging scheme. The Plaintiff States alleged that Defendants conspired to rig bids at public stamp auctions for approximately seventeen years.
In re Minolta Camera Products Antitrust Litigation, 668 F. Supp. 456 (D. Md 1987)
The Plaintiff States sought damages on behalf of their resident consumers, alleging that the Minolta Corporation (Minolta) conspired with several retailers to fix the prices for which its products were sold at retail.
New York v. Keds Corporation, 1994 WL 97201, 1994-1 Trade Cas. (CCH) ¶ 70,549 (S.D.N.Y.1994)
Plaintiff States sought damages and injunctive relief, alleging that Keds Corporation (Keds) conspired with its dealers to set minimum retail prices for which the dealers could sell their products.
U.S. v. Cargill Inc., No. 6:97-CV-6161 (W.D.N.Y. July 22, 1997)
The U.S. and Plaintiff States sought to enjoin Akzo and Cargill, Inc. (Cargill) from consummating their merger, arguing that the merger would substantially reduce competition in the mining and sale of salt products.
U.S. v. Sony Corporation of America, 1998 U.S. Dist. LEXIS 20815, 2000-1 Trade Cas. (CCH) 72,787 (S.D.N.Y. 1998)
U.S. and the States sought to enjoin Loews Theatres, Inc. (Loews) and Cineplex from consummating their merger, arguing that the merger would significantly impair competition in first screening movie theaters.
In re Clozapine Antitrust Litigation, MDL No. 874 (N.D. Ill. 1991)
Plaintiff States sought monetary damages and injunctive relief against Sandoz Pharmaceuticals Corporation (Sandoz), alleging the company unlawfully required those who purchased its drug, Clozapine, to also purchase distribution and patient monitoring services from Sandoz.
In Re: Insurance Antitrust Litigation, 938 F.2d 919, 1991-1 Trade Cases (CCH) & 69,460
Plaintiff States sought damages and injunctive relief, alleging that Defendant reinsurers, brokers and trade organizations conspired to reduce the availability to public entities of commercial general liability insurance during the mid-1980s.
New Jersey v. Exxon Corp. No. 1:99CV03183 (D.D.C. Nov. 30, 1999); Alaska v. Exxon Corp. No. A99-618-CV (D. Alaska, Nov. 30, 1999); Texas v. Exxon Corp. No. 3-99CV 2709-L (N.D. Texas, Dallas, Dec. 3, 1999); California v. Exxon
Plaintiff States sought to enjoin the merger between Exxon Corporation (Exxon) and Mobil Corporation (Mobil), alleging that the merger would violate Section 7 of the Clayton Act because the acquisition would substantially lessen competition and/or tend to lessen competition in relevant markets in each of the States.
In re Compact Disc Minimum Advertised Price Antitrust Litigation MDL No. 1361 (D. Me. 2002) MDL-1391; No. 00-CIV-5853 (BSJ) (S.D.N.Y Aug. 8, 2000) (complaint)
Plaintiff States sought damages and injunctive relief, alleging that Defendant CD distributors unlawfully conspired to implement stringent minimum advertised price (MAP) policies in violation of antitrust laws.
In re: Buspirone Antitrust Litigation,Case No. 01 CV 11401, MDL 1410, MDL 1413 (S .D.N.Y.) (see also Ohio v. Bristol Myers Squibb
Plaintiff States sought damages and injunctive relief, alleging that Bristol-Myers Squibb Co. (BMS) attempted to maintain an unlawful monopoly on buspirone hydrochloride, a medication used to treat generalized anxiety. In settling, BMS agreed to a stipulated injunction and to reimburse consumers and state and local public entities for overcharges. In 2008, plaintiff states sued BMS for failing to report accurately to the states, pursuant to the settlement, a patent arrangement involving the drug Plavix. The company pleaded guilty to lying to the FTC and the states recovered $1.1 million in fines.
